Galapagos NV DPO Ratio 2011-2026 | GLPG

Annual DPO Ratio Galapagos NV

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	81.9	98.6	260	167	-

All numbers in EUR currency

Maximum	Minimum	Average
260	81.9	152

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	5.06 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	5.24 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Compugen Ltd. CGEN	82.7	$ 2.66	0.38 %	$ 249 M	Israel
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	2.52 K	-	-34.95 %	$ 21.5 M	Germany
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Celyad Oncology SA CYAD	55.8 K	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	135	-	-7.31 %	$ 87 M	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	1.79 K	-	-4.36 %	$ 27 M	USA
Coherus BioSciences CHRS	507	$ 1.7	3.35 %	$ 199 M	USA
Anika Therapeutics ANIK	43.4	$ 14.71	-1.21 %	$ 211 M	USA
Celldex Therapeutics CLDX	4.06 K	$ 31.64	2.56 %	$ 2.1 B	USA
Advaxis ADXS	85.6 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	133	$ 21.54	2.01 %	$ 2.74 B	USA
Ampio Pharmaceuticals AMPE	4.62 K	-	-11.43 %	$ 502 K	USA